Basic Treatment Planning

With new techniques, carcinogenesis needs to be monitored; there might also be unsuspected regions of high dose within the patient ICRU: “… The volume within the patient excluding any delineated OAR and the CTV(s) should be identified as the “remaining volume at risk” (RVR)” Volumes in ICRU78 and ICRU83